Risk of anaphylaxis in opioid dependent persons: effects of heroin versus substitution substance
Open Access
- 27 February 2014
- journal article
- research article
- Published by Springer Nature in Substance Abuse Treatment, Prevention, and Policy
- Vol. 9 (1) , 12
Abstract
Across Europe, illicit drug-related mortality has not declined despite ever increasing prevention measures. The cause of these deaths has traditionally been associated with overdose. Previous findings have revealed the appearance of non-lethal opioid concentrations, leading us to investigate a further cause of death. The symptoms of heroin intoxication with asphyxia and/or cardiovascular involvement resemble anaphylaxis, and therefore it has been speculated that such deaths might be caused by an allergic reaction. The study´s aims were to investigate levels of allergic mediators in long-term injecting drug users (IDU) compared to healthy controls and to determine if oral opioid substitution therapy (OST) resulted in similar allergic symptoms to those reported by IDU after intravenous (IV) heroin use.Keywords
This publication has 55 references indexed in Scilit:
- Mortality among people who inject drugs: a systematic review and meta-analysisBulletin of the World Health Organization, 2013
- Usefulness of post mortem determination of serum tryptase, histamine and diamine oxidase in the diagnosis of fatal anaphylaxisForensic Science International, 2011
- Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviewsThe Lancet, 2011
- World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy-immunology specialists in health care settingsAnnals of Allergy, Asthma & Immunology, 2010
- AnaphylaxisJournal of Allergy and Clinical Immunology, 2010
- IgE, mast cells, basophils, and eosinophilsJournal of Allergy and Clinical Immunology, 2010
- Opiates, mast cells and histamine releaseLife Sciences, 1993
- Human Basophil/Mast Cell ReleasabilityAnesthesiology, 1992
- Adverse Effects of Systemic Opioid AnalgesicsDrug Safety, 1992
- Tryptase Levels as an Indicator of Mast-Cell Activation in Systemic Anaphylaxis and MastocytosisNew England Journal of Medicine, 1987